At the American Diabetes Association’s (ADA) virtual 81st Scientific Session, a symposium was presented wherein Ian J. Neeland, Cleveland, Ohio, USA, discussed the role of intra-organ fat in obesity pathogenesis and Roy Taylor, Newcastle upon Tyne, UK, highlighted how analysis of intra-hepatic and intra-pancreatic fat using MRI can lead to insights into practical therapy for achieving effective weight loss and remission of type 2 diabetes. This article reviews their findings and how weight loss interventions may not only help reduce cardiovascular and metabolic disease risk, but also reverse type 2 diabetes for some patients.
EMJ Diabetes 9 [Supplement 1] . 2021
October 2021
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given